(3-R,4-S,5-S)-3,5-BIS-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-4-METHYL-6-OXOHEPTANAL
Compound with spectra: 1 NMR
![(3-R,4-S,5-S)-3,5-BIS-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-4-METHYL-6-OXOHEPTANAL](/api/compound/Ke2fYe7iYnG.png?ph=true&h=300&w=458 "(3-R,4-S,5-S)-3,5-BIS-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-4-METHYL-6-OXOHEPTANAL")
| SpectraBase Compound ID | Ke2fYe7iYnG |
|---|---|
| InChI | InChI=1S/C20H42O4Si2/c1-15(17(13-14-21)23-25(9,10)19(3,4)5)18(16(2)22)24-26(11,12)20(6,7)8/h14-15,17-18H,13H2,1-12H3/t15-,17+,18-/m0/s1 |
| InChIKey | BWAYFAGVUFWRQP-JQHSSLGASA-N |
| Mol Weight | 402.7 g/mol |
| Molecular Formula | C20H42O4Si2 |
| Exact Mass | 402.262163 g/mol |
| Enantiomer InChIKey | BWAYFAGVUFWRQP-BPQIPLTHSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
5-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-7-triethylsilyloxy-3-octanone
3-BETA-[(TERT.-BUTYL)-DIMETHYLSILYLOXY]-2-ALPHA-METHYL-5-BETA-(1-METHYLETHENYL)-CYCLOHEXAN-1-ALPHA-OL
(3R,5R)-3,5-Bis[(tert-butyldimethylsilyl)oxy]-4-[(trimethylsiloxy)cyclohexanone
(+/-)-(2RS,3SR,4RS,6SR)-4-(TERT.-BUTYLDIMETHYLSILYLOXY)-2,3-DIHYDROXY-6-METHYLCYCLOHEXANONE
tert-Butyldimethylsilyl (2R,3R)-3-((tert-Butyldimethylsilyl)oxy)-8,8,9,9-tetrachloro-2-methyldecanoate
TERT.-BUTYLDIMETHYLSILYL-(2R,3R)-3-((TERT.-BUTYLDIMETHYLSILYL)-OXY)-2-METHYL-8,8,9,9-TETRACHLORODECANONATE
Ethyl (1R,2S)-(+)-2-[(thexyldimethylsilyl)oxy]-1-cyclopentanecarboxylate
(E,4R,5S,6R,7R,8S)-1-bromanyl-7-[tert-butyl(dimethyl)silyl]oxy-2,4,6,8-tetramethyl-dec-2-en-5-ol
[(3'R,5'R)-3',5'-Bis[(tert-butyldimethylsilyl)oxy]-4'-hydroxycyclohexylidene]acetic acid methyl ester
(1S,4S,5S)-5-[tert-butyl(dimethyl)silyl]oxy-2-bicyclo[2.2.2]octanone
| Title | Journal or Book | Year |
|---|---|---|
| Structure−Function Relationships and Crystal Structures of the Vitamin D Receptor Bound 2α-Methyl-(20S,23S)- and 2α-Methyl-(20S,23R)-epoxymethano-1α,25-dihydroxyvitamin D3 | Journal of Medicinal Chemistry | 2010 |